Tcd emboli detect w/o inj
93892 reports the primary emboli-detection service without intravenous microbubble injection; 93897 represents each additional 30 minutes and must accompany the primary service.
CMS RVU26D · Effective 2026-10-01
Reports each additional 30 minutes of transcranial Doppler emboli detection without intravenous microbubble injection, beyond the primary monitoring service. Compare 93897 office and facility rates across CMS payment localities in Rhode Island.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
Rhode Island has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
$244.61
1 of 1 localities have a supported rate.
Payment area: Rhode Island
One mapped payment locality.
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Vascular ultrasound
Reports each additional 30 minutes of transcranial Doppler emboli detection without intravenous microbubble injection, beyond the primary monitoring service.
This add-on represents another 30 minutes of transcranial Doppler monitoring for embolic signals in the intracranial arteries, without intravenous microbubble injection. A vascular sonographer typically acquires the Doppler data in a vascular laboratory or hospital setting; a physician with appropriate expertise interprets the diagnostic study. The additional interval may extend monitoring when emboli surveillance requires more time than the primary service covers.
Report 93897 only with the primary emboli-detection service, 93892, and document the additional monitoring time and the study findings. It is not a stand-alone report for the initial monitoring service. CMS treats it as an add-on paid within the primary procedure’s global period. The diagnostic test has professional and technical components: append modifier 26 for the interpretation or TC for equipment and staff; without either modifier, the claim represents the global service.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Office rates for Rhode Island, from the same CMS release.
Tcd emboli detect w/o inj
93892 reports the primary emboli-detection service without intravenous microbubble injection; 93897 represents each additional 30 minutes and must accompany the primary service.
Tcd std icr art ven-art shnt
93893 is for emboli detection with intravenous microbubble injection. Choose 93897 only for additional monitoring time without that injection.
93898 evaluates for a venous-to-arterial shunt using microbubble injection; 93897 extends non-injection emboli monitoring.
93886 reports a complete intracranial transcranial Doppler study, while 93897 adds time to the primary emboli-detection service.
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Office / nonfacility
$244.61
Facility
Unavailable
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 93897 in Rhode Island.
PPRRVU2026_Oct_nonQPP.csv
12,299
GPCI2026.csv
92
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.71 | × 1.019 | 0.7235 |
| Practice expense | 6.32 | × 1.033 | 6.5286 |
| Malpractice | 0.08 | × 0.892 | 0.0714 |
| Total RVUs | 7.3234 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Rhode Island$244.61
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0.71 | 1.019 |
| Practice expense | 6.32 | 1.033 |
| Malpractice | 0.08 | 0.892 |
(0.71 × 1.019 + 6.32 × 1.033 + 0.08 × 0.892) × $33.4009 = $244.61
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Use 93892 for the primary emboli-detection service without intravenous microbubble injection. Report 93897 for each additional 30 minutes of monitoring, with 93892.
No. It is an add-on code and must be reported with its primary emboli-detection service, 93892.
Modifier 26 identifies the professional interpretation, and modifier TC identifies the technical service. Without either modifier, the claim represents the global service.
Document the total monitoring time, including the additional interval, and the findings from the transcranial Doppler emboli-detection study.
93897 adds monitoring time without intravenous microbubble injection. 93893 describes emboli detection with microbubble injection, rather than additional time for the non-injection service.
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.